Everything by Jon.

Economy

Why France’s Economy Matters So Much: France by the Numbers

Apr 24, 2017 Investing

Top Analyst Upgrades and Downgrades: AK Steel, Amazon, AngloGold Ashanti, Bank of America, GE, Disney, Xilinx and More

Apr 24, 2017 Industrials

Why Merrill Lynch Still Sees Big Upside for GE After Earnings

Apr 22, 2017 Technology

How Analysts See Qualcomm and NXP After Earnings

Apr 20, 2017 Investing

Top Analyst Upgrades and Downgrades: Amazon, Gap, Goldman Sachs, Starbucks, Time Warner and Many More

Apr 20, 2017 Companies and Brands

Why Credit Suisse Sees Big Upside for Coca-Cola as a Total Beverage Company

Apr 19, 2017 Economy

IMF Gives an Upgrade-Lite Outlook for Global Growth

Apr 18, 2017 Banking, finance, and taxes

Bank of America Delivers Earnings Growth and Still at Discount to Book Value

Apr 18, 2017 Investing

Top Analyst Upgrades and Downgrades: Alibaba, Apple, Match, McDonald’s Netflix, Synacor, IAC, Check Point, Stratasys and More

Apr 18, 2017 Technology

RBC Joins Analyst Target Hike Brigade for Apple

Apr 17, 2017 Health and Healthcare

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Apr 17, 2017 Economy

Empire Manufacturing Shows Much More Modest Growth Under Expectations

Apr 17, 2017 Investing

Top Analyst Upgrades and Downgrades: Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald’s, Snap and More

Apr 17, 2017 Commodities & Metals

Analysts Have Big Targets for 3 Metals and Mining Stocks

Apr 15, 2017 Media

The Case for an Apple-Disney Merger, More Hope Than Reality

Apr 13, 2017 Investing

Top Analyst Upgrades and Downgrades: Adobe, ClubCorp, Oracle, Silver Wheaton, Weatherford, Yahoo and Many More

Apr 13, 2017 Investing

7 Stocks With Short Interest Screaming Higher

Apr 12, 2017 Investing

Top Analyst Upgrades and Downgrades: Adobe, HP, Lululemon, Neurocrine Bio, Pepsi, Under Armour and Many More

Apr 12, 2017 Investing

9 Stocks Under $10 Up Over 100% So Far in 2017, Some Exponentially

Apr 12, 2017 Health and Healthcare

Analysts Keep Stacking Up Higher Targets and Expectations for Eli Lilly

Apr 11, 2017